Tutorial reduces protocol deviations in multicenter ACTG trials with pharmacology endpoints

HIV Clinical Trials

Volumn 7, Issue 4, 2006, Pages 203-209

  DiFrancesco, Robin ^a   Rosenkranz, Susan L ^b   Craft, Jean ^c   Morse, Gene D ^a  

^a UNIVERSITY AT BUFFALO   (United States)

^b CENTER FOR BIOSTATISTICS IN AIDS RESEARCH   (United States)

^c INDIANA UNIVERSITY   (United States)

Author keywords

Data accuracy; Quality assurance; Tutorial

Indexed keywords

ACCURACY; ANALYTICAL ERROR; ARTICLE; BLOOD SAMPLING; CLINICAL COMPETENCE; CLINICAL PROTOCOL; CLINICAL RESEARCH; DATA ANALYSIS; DRUG MONITORING; DRUG RESEARCH; HUMAN; HUMAN EXPERIMENT; INFORMATION PROCESSING; INTERNET; MEDICAL AUDIT; MEDICAL EDUCATION; NORMAL HUMAN; NURSE RESEARCHER; PRIORITY JOURNAL; QUALITY CONTROL; RETROSPECTIVE STUDY; SAMPLING ERROR;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ANTI-HIV AGENTS; CLINICAL PROTOCOLS; CLINICAL TRIALS; HUMANS; MULTICENTER STUDIES; NURSE PRACTITIONERS; PHARMACOLOGY; QUALITY ASSURANCE, HEALTH CARE;

EID: 33750857287     PISSN: 15284336     EISSN: None     Source Type: Journal    
DOI: 10.1310/hct0704-203     Document Type: Article

References (9)

1. DiFrancesco R, Holland DT, Schiffhauer JE, Robbins BL, Tooley KM, Morse GD. A quality assurance program for AIDS clinical trials group pharmacology studies. Qual Assur J. 2005;9:23-30.
2. StatXact 7 PROCs for SAS Users. A software package for exact nonparametric inference. Cambridge, MA: Cytel Inc; 2005.
3. Blyth CR, Still HA. Binomial confidence intervals. J Am Stat Assoc. 1983;78:108-116.
4. Fletcher CV, Acosta EP, Cheng H, et al., for the ACTG 884 Protocol Team. Competing drug-drug interactions among multidrug antiretroviral regimens used in the treatment of HIV-infected subjects: ACTG 884. AIDS. 2000;14(16): 2495-2501.
5. Fletcher CV, Jiang H, Brundage RC, et al. Sex-based differences in saquinavir pharmacology and virologic response in AIDS Clinical Trials Group Study 359. J Infect Dis. 2004;189:1176-1184.
6. DiCenzo R, Forrest A, Squires KE, et al., and the Adult AIDS Clinical Trials Group Protocol 368/886 Study Team. Indinavir efavirenz, and abacavir pharmacokinetics in human immunodeficiency virus-infected subjects. Antimicrob Agents Chemother. 2003;47(6):1929-1935.
7. Haas DW, Ribaudo HJ, Kim RB, et al. Pharmacogenetics of efavirenz and central nervous system side effects: an Adult AIDS Clinical Trials Group study. AIDS. 2004;18(18):2391-2400.
8. Ribaudo HJ, Haas DW, Tierney C, et al. Pharmacogenetics of plasma efavirenz exposure after treatment discontinuation: an adult AIDS Clinical Trials Group Study. Clin Infect Dis. 2006;42:401-407.
9. Jian-Feng L, Blaschke TF, Flexner C, Rosenkranz SL, Sheiner LB. Model-based analysis of the pharmacokinetic interactions between ritonavir, nelfinavir, and saquinavir after simultaneous and staggered oral administration. Drug Metabol Disposition. 2002:30;1455-1461.